Detalhe da pesquisa
1.
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.
Int J Mol Sci
; 22(15)2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360578
2.
Immunological Landscape of HER-2 Positive Breast Cancer.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804943
3.
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer.
Cancers (Basel)
; 13(11)2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34200463